356 related articles for article (PubMed ID: 29129972)
21. Colorectal cancer in inflammatory bowel disease: review of the evidence.
Keller DS; Windsor A; Cohen R; Chand M
Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
[TBL] [Abstract][Full Text] [Related]
22. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR
Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782
[TBL] [Abstract][Full Text] [Related]
23. The Protective Role of
Lee YK; Mehrabian P; Boyajian S; Wu WL; Selicha J; Vonderfecht S; Mazmanian SK
mSphere; 2018 Nov; 3(6):. PubMed ID: 30429227
[TBL] [Abstract][Full Text] [Related]
24. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
25. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.
Alpert L; Yassan L; Poon R; Kadri S; Niu N; Patil SA; Mujacic I; Montes D; Galbo F; Wurst MN; Zhen CJ; Cohen RD; Rubin DT; Pekow JR; Weber CR; Xiao SY; Hart J; Segal J; Setia N
Hum Pathol; 2019 Jul; 89():44-50. PubMed ID: 31054900
[TBL] [Abstract][Full Text] [Related]
26. The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.
Luo C; Zhang H
Mediators Inflamm; 2017; 2017():5126048. PubMed ID: 28852270
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines.
Porter RJ; Arends MJ; Churchhouse AMD; Din S
J Crohns Colitis; 2021 Dec; 15(12):2131-2141. PubMed ID: 34111282
[TBL] [Abstract][Full Text] [Related]
28. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
29. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
30. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
[TBL] [Abstract][Full Text] [Related]
32. Research progress on the carcinogenesis mechanism of inflammation in ulcerative colitis: a narrative review.
Tang P; Zha L; Ye C; Zhou L
Ann Palliat Med; 2021 Nov; 10(11):11994-12002. PubMed ID: 34872322
[TBL] [Abstract][Full Text] [Related]
33. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
34. mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis.
Brandt M; Grazioso TP; Fawal MA; Tummala KS; Torres-Ruiz R; Rodriguez-Perales S; Perna C; Djouder N
Cell Metab; 2018 Jan; 27(1):118-135.e8. PubMed ID: 29275959
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.
Hirsch D; Wangsa D; Zhu YJ; Hu Y; Edelman DC; Meltzer PS; Heselmeyer-Haddad K; Ott C; Kienle P; Galata C; Horisberger K; Ried T; Gaiser T
Clin Cancer Res; 2018 Oct; 24(20):4997-5011. PubMed ID: 29967250
[No Abstract] [Full Text] [Related]
36. Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future.
Zhiqin W; Palaniappan S; Raja Ali RA
Intest Res; 2014 Jul; 12(3):194-204. PubMed ID: 25349593
[TBL] [Abstract][Full Text] [Related]
37. Colorectal Cancer in Inflammatory Bowel Disease.
Nebbia M; Yassin NA; Spinelli A
Clin Colon Rectal Surg; 2020 Sep; 33(5):305-317. PubMed ID: 32968366
[TBL] [Abstract][Full Text] [Related]
38. PPARδ and PGE
Wang D; DuBois RN
Inflamm Cell Signal; 2014 Oct; 1(6):. PubMed ID: 26290896
[TBL] [Abstract][Full Text] [Related]
39. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer.
Velikova TV; Miteva L; Stanilov N; Spassova Z; Stanilova SA
World J Gastroenterol; 2020 Apr; 26(16):1912-1925. PubMed ID: 32390702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
